CytoSorbents Corp. (CTSO)
0.4698
0.00 (0.00%)
USD |
NASDAQ |
May 20, 16:00
CytoSorbents Cash from Financing (Quarterly) : 0.00 for March 31, 2026
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Delcath Systems, Inc. | -2.381M |
| Quest Diagnostics, Inc. | -152.00M |
| Danaher Corp. | 46.00M |
| NovelStem International Corp. | 0.2282M |
| Illumina, Inc. | -251.00M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.162M |
| Cash from Investing (Quarterly) | -0.046M |
| Free Cash Flow | -10.59M |
| Free Cash Flow Per Share (Quarterly) | -0.0197 |
| Free Cash Flow to Equity (Quarterly) | -1.396M |
| Free Cash Flow to Firm (Quarterly) | -0.377M |
| Free Cash Flow Yield | -35.29% |